{"DataElement":{"publicId":"7373709","version":"1","preferredName":"Visceral Kaposi Sarcoma Lesion Evaluation Status","preferredDefinition":"Text term(s) that represents the status of the visceral Kaposi sarcoma lesion evaluation.","longName":"QSSORES_QSLOC1","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"7373705","version":"1","preferredName":"Visceral Kaposi Sarcoma Lesion Evaluation","preferredDefinition":"Of, or relating to, or affecting the internal organs._A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"7373694v1.0:2239847v1.0","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"7373694","version":"1","preferredName":"Visceral Kaposi Sarcoma Lesion","preferredDefinition":"Of, or relating to, or affecting the internal organs.:A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","longName":"C25315:C9087:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Visceral","conceptCode":"C25315","definition":"Of, or relating to, or affecting the internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB96437C-22F3-5997-E053-4EBD850A9551","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"ONEDATA","dateModified":"2020-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239847","version":"1","preferredName":"Evaluation","preferredDefinition":"Evaluation; the act of placing value on something.","longName":"C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8188-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-24","modifiedBy":"ONEDATA","dateModified":"2005-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB96437C-231E-5997-E053-4EBD850A9551","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7372147","version":"1","preferredName":"Lesion Evaluation Status","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._A condition or state at a particular time.","longName":"7372147v1.0","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Worse than last assessment","valueDescription":"Worse","ValueMeaning":{"publicId":"2567097","version":"1","preferredName":"Worse","longName":"2567097","preferredDefinition":"In an declined condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Worse","conceptCode":"C71686","definition":"In an declined condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D326-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-10-01","modifiedBy":"MMADDINENI","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB829A82-0334-3149-E053-4EBD850A56B5","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"Better than last assessment","valueDescription":"Better","ValueMeaning":{"publicId":"3139193","version":"1","preferredName":"Better","longName":"3139193","preferredDefinition":"In an improved condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Better","conceptCode":"C71685","definition":"In an improved condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"907812A6-F57F-AF9D-E040-BB89AD432D53","latestVersionIndicator":"Yes","beginDate":"2010-09-17","endDate":null,"createdBy":"SORENSENS","dateCreated":"2010-09-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB829A82-0348-3149-E053-4EBD850A56B5","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"Not assessable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB829A82-035C-3149-E053-4EBD850A56B5","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"No change","valueDescription":"Change","ValueMeaning":{"publicId":"2581582","version":"1","preferredName":"Change","longName":"2581582","preferredDefinition":"alteration or modification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BBB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-01","endDate":null,"createdBy":"UMLLOADER_CAARRAY","dateCreated":"2006-11-01","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB829A82-0370-3149-E053-4EBD850A56B5","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7372146","version":"1","preferredName":"Lesion Evaluation Status","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.:A condition or state at a particular time.","longName":"C3824:C25214:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB829A82-0304-3149-E053-4EBD850A56B5","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB829A82-0315-3149-E053-4EBD850A56B5","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-25","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"QSSORES_QSLOC3","type":"OID, AMC","context":"AMC"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"QSSORES_QSLOC2","type":"OID, AMC","context":"AMC"},{"name":"VIS_KAPOSI_LSN_EVAL_STAT","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Evaluate site lesions","type":"Preferred Question Text","description":"Evaluate site lesions","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB95D502-DA49-5993-E053-4EBD850AF047","latestVersionIndicator":"Yes","beginDate":"2020-07-29","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-29","modifiedBy":"TSESU","dateModified":"2023-08-09","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"}}